Drug factory · FDA FEI 3007317099
Madhu Instruments Private Limited
A-260, Okhla Industrial Area Phase-1, New Deli, India
Serious problems, FDA action at FDA's last inspection, Oct 21, 2022.
Official Action Indicated: inspectors found significant problems and FDA recommended regulatory action, such as a warning letter or import alert.
2 drug inspections on record since 2019: 0 with no problems, 0 with problems fixed voluntarily, 2 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Fluorescein | Makes it | HUB Pharmaceuticals, Inc., Vistamerica USA | 17238-900, 83851-100 |
| Light Green Sf Yellowish | Makes it | HUB Pharmaceuticals, Inc. | 17238-920 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Oct 21, 2022 | Serious problems, FDA action | Drug Quality Assurance | — |
| Aug 16, 2019 | Serious problems, FDA action | Drug Quality Assurance | — |
Registered with FDA for: manufacture.